Sign in

CIK 0001661059

  • Non-accelerated filer
  • Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475231247
Phone
+1 240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
Open-market buys, last 90 days
$140,487
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$140,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$140K 10% owner 3 filings
Date Insider Transaction Shares Price Value Owned after
2025-01-31 Langermann Sol Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +117,375 117,375
2024-03-29 Langermann Sol Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +93,900 93,900
2024-01-31 Langermann Sol Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +117,375 117,375
2023-02-28 Langermann Sol Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +135,000 135,000
2022-01-31 Langermann Sol Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +117,400 117,400
2021-03-15 Langermann Sol Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +100,000 100,000
2020-02-28 Langermann Sol Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +78,200 78,200

Page 1 of 1 · 7 trades